Skip to main content
Premium Trial:

Request an Annual Quote

Nanogen, HandyLab Expand Probe Licensing Deal

NEW YORK (GenomeWeb News) – Nanogen today said that it has expanded a licensing agreement with HandyLab for the firm's probe technology and synthetic nucleic acid chemistries.

San Diego-based Nanogen said that HandyLab has received non-exclusive rights to market, sell, and distribute PCR kits that utilize its Minor Groove Binder Probe technology and related chemistries, dyes, and quenchers for in vitro diagnostic testing. HandyLab will use the technology in its Jaguar System.

HandyLab will pay Nanogen an upfront license fee. Other financial terms of the alliance were not disclosed.

The agreement expands an existing partnership between the firms that began last year when the US Centers for Disease Control and Prevention awarded a $10.4 million contract to Nanogen to develop a multi-analyte molecular diagnostic assay for influenza. That test is being developed for use with a HandyLab microfluidic, real-time PCR Raider instrument.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.